{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-097097","form_type":"8-K","ticker":"BNBX","cik":"0000744452","company_name":"BNB PLUS CORP.","filed_at":"2025-10-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.069118+00:00","generated_at":"2026-05-17T04:40:34.795135+00:00","sec_items":["2.05","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Applied DNA cuts 60% of workforce ($1.4M charges), ticker changes to BNBX Oct 7","bullets":["Reduces workforce by 16 employees (~60%) with estimated pre-tax charges of ~$1.4M for severance and benefits.","Restructuring substantially complete by end of October 2025; annualized cost savings of ~$2.9M expected.","Ticker symbol changes from APDN to BNBX on Nasdaq effective October 7, 2025, reflecting BNB treasury strategy.","Company to focus on yield-generating BNB digital asset treasury and decentralized finance integration.","No stockholder action required; CUSIP and listing unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-097097","json":"https://secwatch.observer/filing/0001104659-25-097097.json","markdown":"https://secwatch.observer/filing/0001104659-25-097097.md","text":"https://secwatch.observer/filing/0001104659-25-097097.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/744452/000110465925097097/0001104659-25-097097-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/744452/000110465925097097/tm2528084d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:40:34.795135+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f76b7720b74a362c516200650dcea616b675384f","claim":"BNB PLUS CORP. announced a restructuring with charges of $1.4 million aggregate pre-tax charges for severance payments, employee benefits, and related costs affecting workforce reduction, reduction of 16 employees (approx. 60%) (reduction of the Company’s current workforce by sixteen employees, or approximately 60%).","evidence_excerpt":"On September 30, 2025, the Board of Directors of Applied DNA Sciences, Inc. (the “ Company ”) authorized, and its officers implemented, a restructuring plan pursuant to which the Company will reduce overall operating expenses to focus resources on its previously announced BNB-focused treasury strategy. The restructuring plan includes a reduction of the Company’s current workforce by sixteen employees, or approximately 60%. The Company estimates that it will incur aggregate pre-tax charges of approximately $1.4 million in connection with the reduction-in-force, primarily consisting of severance payments, employee benefits, and related costs.","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/744452/000110465925097097/0001104659-25-097097-index.htm","confidence":0.95,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Charge","value":"$1.4 million aggregate pre-tax charges for severance payments, employee benefits, and related costs"},{"label":"Affected area","value":"workforce reduction, reduction of 16 employees (approx. 60%)"},{"label":"Headcount","value":"reduction of the Company’s current workforce by sixteen employees, or approximately 60%"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}